18 to 70 years of age; patchy AA with 30% to 80% scalp hair loss
This study is evaluating the safety and tolerability of a topical form of an investigational JAK inhibitor in people with alopecia areata.
You may qualify to participate in this study if you:*
*There are additional requirements as determined by a screening process.
If you qualify, you will need to come to the study center up to 7 times over a 4 month period. At these visits, the study doctor will closely monitor your alopecia areata and discuss your overall experiences with the topical study drug and your participation in the study. Participation in this study is at no cost to you and you will be compensated for your time and travel.
If you would like to learn more about this study, please visit https://alopeciaareatastudy.com/ to evaluate if you may be eligible and then be directed to a research site located close to you. This study is taking place at locations throughout the United States:
